Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Han Q et al. | 2018 | - | magnetic field, 50/60 Hz, co-exposure | - |
| Sanie-Jahromi F et al. | 2018 | - | 50/60 Hz, magnetic field, co-exposure | - |
| Consales C et al. | 2019 | - | magnetic field, 50/60 Hz | - |
| Oladnabi M et al. | 2019 | - | magnetic field, signals/pulses, 50/60 Hz | - |
| Xu A et al. | 2020 | - | magnetic field, 50/60 Hz, low frequency | - |
| Hu Y et al. | 2016 | animal, mouse/3xTg and 129/C57BL/6, whole body | magnetic field, 50/60 Hz | 500 µT |
| Kumlin T et al. | 2002 | animal, mouse/BALB/CŒDBA/2, whole body | magnetic field, 50/60 Hz, co-exposure | 100 µT |
| Lee JS et al. | 2004 | animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 0.1–0.5 mT |
| Kim YW et al. | 2009 | animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 14–200 µT |
| Kim HS et al. | 2014 | animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 2–200 µT |
| Saha S et al. | 2014 | animal, mouse/C57BL/6, whole body: <i>in utero</i> | magnetic field, 50/60 Hz, also other exposures without EMF | 100–300 µT |
| Zhang H et al. | 2016 | animal, mouse/ICR | magnetic field, 50/60 Hz, co-exposure | 8 mT |
| McNamee JP et al. | 2002 | animal, mouse/ICR, whole body | magnetic field, 50/60 Hz | 1 mT |
| Ismael SJ et al. | 1998 | animal, mouse/Swiss, whole body | magnetic field, static magnetic field, 50/60 Hz, DC | 0.4–20 µT |
| Park S et al. | 2015 | animal, rat/Sprague Dawley, whole body | magnetic field, 50/60 Hz | 200 µT |
| Lai H et al. | 2004 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz, co-exposure | 10–500 µT |
| Akdag MZ et al. | 2010 | animal, rat/Sprague-Dawley, whole body | magnetic field, low frequency, 50/60 Hz | 100–500 µT |
| Akdag MZ et al. | 2013 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz | 100–500 µT |
| Duan W et al. | 2014 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz | 500 µT |
| Roushangar L et al. | 2007 | animal, rat/Wistar | magnetic field, 50/60 Hz | 3 mT |
| Ambalayam S et al. | 2022 | animal, rat/Wistar | magnetic field, 50/60 Hz, low frequency | - |
| Kiray A et al. | 2013 | animal, rat/Wistar, whole body | magnetic field, 50/60 Hz | 3 mT |
| Teimori F et al. | 2016 | animal, rat/Wistar, whole body | magnetic field, 50/60 Hz | 3 mT |
| Li Y et al. | 2014 | animal, zebrafish embryos (<i>Danio rerio</i>), whole body | magnetic field, 50/60 Hz | 30–800 µT |
| Hosseinabadi MB et al. | 2019 | human | magnetic field, low frequency, 50/60 Hz, occupational | 11.3–18.9 µT |
| Baharara J et al. | 2016 | intact cell/cell culture, A2780 cells (cisplatin-resistant human ovarian adenocarcinoma cells) | magnetic field, 50/60 Hz, co-exposure | 20 mT |
| Kroupova J et al. | 2007 | intact cell/cell culture, A549 (human adenocarcinoma cell line) | magnetic field, 50/60 Hz | 2 mT |
| Simko M et al. | 1998 | intact cell/cell culture, AFC cells (human amniotic fluid cell line) and SCL II cells (human squamous cell carcinoma cell line) | magnetic field, 50/60 Hz | 1 mT |
| Ding Z et al. | 2017 | intact cell/cell culture, B95-8 cells (marmoset lymphocytes), BALB/3T3 cells (embryonal mouse fibroblasts) | 50/60 Hz, magnetic field, co-exposure | 2.3 mT |
| Maes A et al. | 2015 | intact cell/cell culture, C3A cells (clonal derivative of Hep G2, a human liver carcinoma cell line) | magnetic field, 50/60 Hz | 5–500 µT |
| Tian F et al. | 2002 | intact cell/cell culture, CHO-K1 (Chinese hamster ovary K1) cells (Ku80-proficient) und xrs5 cells (Ku80-defizient; radiation sensitive mutant isolated from CHO-K1 cells) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Reipert BM et al. | 1997 | intact cell/cell culture, FDCP-mix(A4) cell line (mouse bone marrow cells) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 0.2 µT–2 mT |
| Solek P et al. | 2017 | intact cell/cell culture, GC-1 cells (murine spermatogonia cell line); GC-2 cells (murine spermatocyte cell line) | magnetic field, 50/60 Hz, signals/pulses | 2.5–8 mT |
| Kurian MV et al. | 2012 | intact cell/cell culture, H9c2 cells (myoblast from embryonal rat myocard) | magnetic field, 50/60 Hz, co-exposure | 1–240 µT |
| Cios A et al. | 2021 | intact cell/cell culture, HEK293 (kidney cells), 786-O, 769-P, and Caki1 (clear cell renal carcinoma cell lines) | magnetic field, 50/60 Hz | 4.5 mT |
| Ding GR et al. | 2004 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 5 mT |
| Narita K et al. | 1997 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) und peripheral blood cells | magnetic field, static magnetic field, 50/60 Hz | 45–180 mT |
| Robison JG et al. | 2002 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), HL-60R (human acute myeloid leukaemia cells with retinoic acid receptor-alhpa gene mutation) and Raji cells (human Burkitt lymphoma cells) | magnetic field, 50/60 Hz | 150 µT |
| Hisamitsu T et al. | 1997 | intact cell/cell culture, HL-60 and ML-1 cells (human acute myeloid leukaemia cell lines) and human peripheral blood lymphocytes and human peripheral blood polymorphonuclear cells | magnetic field, 50/60 Hz | 45 mT |
| Duong CN et al. | 2016 | intact cell/cell culture, HMO6 cells (human microglial cell line) | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.01–1 mT |
| Kim J et al. | 2010 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line) and IMR90 (human lung fibroblasts) | magnetic field, 50/60 Hz | 3–6 mT |
| Palumbo R et al. | 2006 | intact cell/cell culture, Jurkat cells (T lymphocyte hybridoma cell line) | magnetic field, 50/60 Hz, power transmission line, co-exposure | 1 mT |
| Pang L et al. | 2002 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 4.4–13 mT |
| Santini MT et al. | 2005 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 1–5 mT |
| Garip AI et al. | 2010 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, low frequency, 50/60 Hz | 1 mT |
| Brisdelli F et al. | 2014 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz, co-exposure | 0.01–2 mT |
| Li Y et al. | 2019 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz, also other exposures without EMF | - |
| Berg H et al. | 2003 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) and U937 cells (human leukemic monocyte cell line) and human lymphocytes | magnetic field, 50/60 Hz, co-exposure | 10–35 mT |
| Markkanen A et al. | 2008 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz, co-exposure | 100–300 µT |
| Pirozzoli MC et al. | 2003 | intact cell/cell culture, LAN-5 (human neuroblastoma cells) | magnetic field, 50/60 Hz | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
